Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,199 | Dovepress* | 7,085+ | 427 | 7,512 | |
| PubMed Central* | 2,114 | 488 | 2,602 | ||
| Totals | 9,199 | 915 | 10,114 | ||
| *Since 16 March 2022 | |||||
View citations on PubMed Central and Google Scholar